Gut-Derived Metabolomic Biomarkers as Mediators of the Inflammatory Pathway in Early Diabetic Kidney Disease
International Journal of Molecular Sciences · 05.12.2025 · 26 (24) · 11776
DOI: 10.3390/ijms262411776 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.12.2025. Verfasst von Lavinia Marcu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Division of Nephrology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timis…. Hauptthemen laut MEDLINE: Biomarkers, Diabetic Nephropathies, Metabolomics, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine," Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania,…, Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine,” Victor Babes” University of Medicine and Pharmacy, “Victor Babes” University of Medicine and Pharmacy.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a major complication of type 2 diabetes mellitus (T2DM) and a leading cause of morbidity and mortality. Both metabolic and inflammatory pathways have emerged as potential sources of biomarkers that may improve DKD detection and treatment. This study investigated the relationship between gut-derived metabolites, such as acylcarnitines (ACs), uremic toxins (UTs), polyol pathway intermediates (PIs), and amino acid derivatives (AADs), and renal inflammation markers, detected in serum and urine. It included 20 healthy controls and 90 patients with T2DM, divided into normoalbuminuria, microalbuminuria, and macroalbuminuria. Serum and urine metabolites were analyzed using untargeted and targeted metabolomic assessments, whereas inflammatory markers were quantified using the ELISA technique. Statistical analysis consisted of descriptive statistics followed by univariable and multivariable linear regression analyses. Our findings revealed that serum AADs contribute to renal fibrosis progression, whereas urinary AADs indicate impaired tubular reabsorption in inflammatory conditions. Additionally, UTs and PIs are linked to inflammatory processes mediated by TNF-α but not by early renal fibrosis, whereas serum ACs appear to modulate immune responses, exerting pro-inflammatory and cytotoxic effects on tubular epithelial cells in early DKD. Thus, the metabolic and inflammatory pathways are tightly interconnected and synergistically contribute to the pathogenesis of early DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine II, Division of Nephrology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
- County Emergency Hospital Timisoara, 300723 Timisoara, Romania.
- Research Center for Applied Biotechnology and Molecular Therapy Biodiatech, SC Proplanta, Trifoiului 12G, 400478 Cluj-Napoca, Romania.
- Department of Occupational Health, University of Medicine and Pharmacy "Iuliu Haţieganu", Victor Babes 8, 400347 Cluj-Napoca, Romania.
- Department of Internal Medicine II, Division of Diabetes and Metabolic Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
ORCID-Profile: Lavinia Marcu, Carmen Socaciu, Adrian Vlad, Florica Gadalean, Maria Mogos, Dragos Catalin Jianu, Sorin Ursoniu, Daliborca Vlad, Roxana Popescu, Ligia Petrica
Förderung
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine," Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania,…
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine,” Victor Babes” University of Medicine and Pharmacy
- “Victor Babes” University of Medicine and Pharmacy
- Internal Grant of “Victor Babes” University of Medicine and Pharmacy Timisoara
Zitieren
APA
Marcu, L., Socaciu, C., Socaciu, A. I., Vlad, A., Gadalean, F., Bob, F., Milas, O., Cretu, O. M., Suteanu, A., Glavan, M., Ienciu, S., Mogos, M., Jianu, D. C., Ursoniu, S., Dumitrascu, V., Vlad, D., Popescu, R., & Petrica, L. (2025). Gut-Derived Metabolomic Biomarkers as Mediators of the Inflammatory Pathway in Early Diabetic Kidney Disease. International Journal of Molecular Sciences, 26(24), 11776. https://doi.org/10.3390/ijms262411776
Vancouver
Marcu L, Socaciu C, Socaciu AI, Vlad A, Gadalean F, Bob F, et al. Gut-Derived Metabolomic Biomarkers as Mediators of the Inflammatory Pathway in Early Diabetic Kidney Disease. International Journal of Molecular Sciences. 2025;26(24):11776. doi:10.3390/ijms262411776
BibTeX
@article{Marcu2025,
author = {Marcu, Lavinia and Socaciu, Carmen and Socaciu, Andreea Iulia and Vlad, Adrian and Gadalean, Florica and Bob, Flaviu and Milas, Oana and Cretu, Octavian Marius and Suteanu, Anca and Glavan, Mihaela and Ienciu, Silvia and Mogos, Maria and Jianu, Dragos Catalin and Ursoniu, Sorin and Dumitrascu, Victor and Vlad, Daliborca and Popescu, Roxana and Petrica, Ligia},
title = {Gut-Derived Metabolomic Biomarkers as Mediators of the Inflammatory Pathway in Early Diabetic Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {24},
pages = {11776},
doi = {10.3390/ijms262411776}
}
EUVIMED